Research Institutions

Latest research findings, studies and research developments.

Why is yogurt good for us?
Research Institutions

Why is yogurt good for us?

Genghis Khan supposedly fed it to his troops for strength and bravery. He might have been onto something.

📅 2026-09-02 19:30:12    •    Harvard Gazette
New research shows a neutrino laser is impossible
Research Institutions

New research shows a neutrino laser is impossible

Due to physical and fundamental limitations, an earlier proposal for producing laserlike beams of neutrinos cannot be achieved, scientists report.

📅 2026-09-02 14:00:00    •    MIT News
Official news regarding the CERN Safety Rules: Storage of hazardous chemical agents (HCA)
Research Institutions

Official news regarding the CERN Safety Rules: Storage of hazardous chemical agents (HCA)

Official news regarding the CERN Safety Rules: Storage of hazardous chemical agents (HCA) Written by: HSE Department — The CERN Safety Rules listed below have been published on the dedicated CERN website: The Safety Guidelines (SG) provide detailed instructions for the implementation of CERN Safety Rules. Compliance with a Safety Guideline provides a presumption of […]

📅 2026-09-02 12:41:10    •    CERN
Exceptional transport operations to make way for HiLumi LHC
Research Institutions

Exceptional transport operations to make way for HiLumi LHC

We often hear about the remarkable components of the accelerators, but transporting this equipment sometimes requires measures that are just as impressive. Over the course of the third long shutdown (LS3), which started this summer, entire sections of the Large Hadron Collider and its detectors will be dismantled in order to make room for the […]

📅 2026-09-02 12:37:42    •    CERN
Reminder: how CERN engages with media and content creators
Research Institutions

Reminder: how CERN engages with media and content creators

Media and social media content creators (influencers) can offer a great opportunity to tell CERN’s story to a wider audience, but unauthorised visits or sponsored content can be potential risks for CERN’s reputation. For this reason, we would like to remind the CERN community (staff, graduates, apprentices, associates, users, students and contractors) that the Press […]

📅 2026-09-02 10:33:47    •    CERN
CERN’s radiation protection training programme evolves to better support CERN activities
Research Institutions

CERN’s radiation protection training programme evolves to better support CERN activities

To be better adapted to the operational needs of CERN’s activities, and to reflect modern learning practices, the radiation protection training programme has been revised by the Safety Training Service in collaboration with HSE and specialists from other CERN departments. What’s new? The revised programme is available in the Safety / Radiation Protection (RP) catalogue […]

📅 2026-09-02 09:51:17    •    CERN
Niels Doble (1938–2026)
Research Institutions

Niels Doble (1938–2026)

Niels Doble (1938–2026) — Niels Doble, born on 2 May 1938, passed away on 8 August 2026 after a short illness. Niels was best known for his pivotal contributions to the initial design and subsequent operation of the North Area at the Super Proton Synchrotron (SPS) complex. Niels studied physics at the University of Bristol. […]

📅 2026-09-02 09:49:49    •    CERN
LS3 Safety Spotlight: coordinating activities at CERN: declaring interventions – a key step
Research Institutions

LS3 Safety Spotlight: coordinating activities at CERN: declaring interventions – a key step

As mentioned in our June and July articles, CERN has put in place a structure to meet the need to manage and oversee concurrent activities during Long Shutdown 3 (LS3). One of the key measures is systematically declaring interventions. Why declare your activities? This is a key step in obtaining formal authorisation to carry out […]

📅 2026-09-02 09:39:15    •    CERN
Strange encounters with family
Research Institutions

Strange encounters with family

For photography scholar, albums are a poignant reminder of the details a picture leaves out

📅 2026-09-01 19:28:22    •    Harvard Gazette
Pre-eclampsia discovery could lead to new test and treatments for at-risk pregnancies
Research Institutions

Pre-eclampsia discovery could lead to new test and treatments for at-risk pregnancies

Pre-eclampsia discovery could lead to new test and treatments for at-risk pregnancies Craig Brierley Tue, 09/01/2026 - 10:00 The discovery helps explain why placental cells fail to properly ‘invade’ the uterus in these two related conditions and could lead to the development of tests to help identify those at greatest risk and new treatments for the conditions.Pre-eclampsia affects around one in 20 pregnancies worldwide and is a leading cause of maternal and fetal health complications, contributing significantly to mortality rates of mothers and babies worldwide. Fetal growth restriction, where a baby does not reach its biological growth potential in the womb, affects roughly 3% to 10% of pregnancies in high-income countries and up to one in five pregnancies globally. It is a leading cause of complications in the womb and in newborns, including stillbirth.Both of these conditions are known to be linked to problems with the placenta not developing properly early in pregnancy, in particular a failure of specialised placental cells known as the extravillous trophoblast (EVT) to invade the mother’s womb and establish a healthy blood supply.Professor Gordon Smith, Head of the Department of Obstetrics and Gynaecology, University of Cambridge, said: “As part of normal development, the placenta invades into the tissues of the mother’s womb. Of all mammals, humans have the deepest placental invasion, which reflects the massive demands of oxygen and nutrients required to manufacture the most complex machine ever known, the human brain.“When this process goes wrong and specialist placental cells fail to adequately invade the uterus, it results in a placenta and fetus that are deprived of nutrients and oxygen, leading to pre-eclampsia and fetal growth restriction. But until now, the reason for this failed invasion has been obscure.”To better understand this process, Professor Smith and colleagues from the Department of Obstetrics and Gynaecology and The Loke Centre for Trophoblast Research at the University of Cambridge analysed serum samples taken from pregnant women at around week 12 of their pregnancies who had been recruited to the Pregnancy Outcome Prediction Study (POPS) at the Rosie Hospital, part of Cambridge University Hospitals NHS Foundation Trust.The researchers looked retrospectively for ‘red flags’ present in those women whose pregnancies went on to be affected by pre-eclampsia or fetal growth restriction. Their findings are published today in Nature Medicine.The researchers found that low circulating levels of a protein known as isthmin-2 (ISM2) around three months into the pregnancy was the strongest indicator that the pregnancy would go on to face problems with pre-eclampsia or fetal growth restriction.ISM2 and its associated mRNA – a molecule that carries instructions from DNA to the part of the cell that makes proteins – are produced almost exclusively in the placenta and, within the placenta, ISM2 mRNA is found in greatest abundance in EVTs. To test whether this association was likely to be a cause of the problems, the team used a laboratory technique to switch off or greatly reduce production of ISM2 in human trophoblast stem cells. The trophoblast is the outer layer to the early-stage embryo, and these stem cells can normally develop into the outer layer of the placenta. However, although the cells still survived and grew normally in the absence of ISM2, they failed to turn into invasive EVT cells.In 3D cellular models known as placental organoids – essentially, ‘mini-placentas’ – the cells stopped spreading into surrounding material, which was mimicking the uterus. In other words, without ISM2, the cells lose their ability to become the type of cells that burrow into the womb and establish blood flow.Remarkably, when human kidney cells – which do not normally make the protein – were forced to make ISM2, they became more invasive in cell culture.Professor Smith, who is also a consultant in maternal and fetal medicine at The Rosie, added: “This has major implications for care in pregnancy. Early pregnancy maternal levels of isthmin-2 are much better at predicting complications than existing tests, so it could enable us to develop better ways of identifying those pregnancies at greatest risk. “It also gives us a potential way to prevent these conditions from happening, if we can find a way to stimulate production of IMS2 in the placenta. Not only that, but blocking it might prevent the need for surgery for complications where the placenta has implanted in the wrong place, such as ectopic and caesarean scar pregnancies.”Professor Steve Charnock-Jones, from the Department of Obstetrics and Gynaecology, said: “Every pregnancy carries with it a risk of pre-eclampsia and fetal restricted growth, and this is even more so the case in low- and middle-income countries. Now that we know what goes wrong, we may be in a better position to make a major difference to pregnancy outcomes, protecting the health and lives of millions of mothers and their babies every year.”The researchers identified the protein by studying a sample of more than 200 women who subsequently experienced pre-eclampsia and/or fetal growth restriction and more than 200 women with normal pregnancies. The findings were validated by studying samples from Swedish pregnant women, including more than 100 cases and 200 controls.The research was largely funded by Wellcome Leap, with additional support by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre: Cambridge and the Medical Research Council.ReferenceMiao, R, Gong, S, Sovio, U & Aye, ILMH et al. Isthmin-2 is essential for extravillous trophoblast invasion and is a first trimester predictor of preeclampsia and fetal growth restriction. Nat Med; 1 Sept 2026; DOI: 10.1038/s41591-026-04573-6 Now that we know what goes wrong, we may be in a better position to make a major difference to pregnancy outcomes, protecting the health and lives of millions of mothers and their babies every year Steve Charnock-Jones ManuelTheLensman Pregnant woman holding her stomach Yes Licence type Public Domain

📅 2026-09-01 09:00:00    •    Cambridge News
“You're going to see the impact in 10 years” - President Kornbluth returns to GBH’s “Boston Public Radio” to discuss scientific funding and curiosity driven research
Research Institutions

“You're going to see the impact in 10 years” - President Kornbluth returns to GBH’s “Boston Public Radio” to discuss scientific funding and curiosity driven research

President Sally Kornbluth took to GBH’s “Boston Public Radio” (BPR) to discuss the value of scientific research amid cuts to federal funding and the new endowment tax impacting MIT and other universities. In her wide-ranging conversation with hosts Jim Braude and Margery Eagan, Kornbluth highlighted ‘Curiosity on a mission,’ MIT’s support for quantum technology, artificial intelligence and research—and where to get soft serve ice cream. “The best science is scientists just following their instincts, trying to find the answers to fundamental questions,” said Kornbluth.Scientific discovery is born from a long sequence of experiments, funded largely by federal grants, “but it's not just scienti...

📅 2026-09-01 04:00:00    •    MIT News
Ila Kumar: Innovating with communities
Research Institutions

Ila Kumar: Innovating with communities

The PhD student works to give young people an active role in shaping digital technologies that can support their own well-being.

📅 2026-09-01 04:00:00    •    MIT News
Translating economic growth into better lives
Research Institutions

Translating economic growth into better lives

Graduate student Lyonel Tanganco investigates how to improve public policy interventions and address challenges in nutrition, climate, and development.

📅 2026-08-31 20:40:00    •    MIT News